Results 121 - 130 of 857 : Previous 9 10 11 12 13 14 15 16 17 Next
The Downside of Dollar-Cost Averaging
Remember the trend -- it's not always a friend of this approach.
More acquisitions already?
Let This Winning Combination Make You Wealthy
Dividend stocks that can grow are rare but valuable.Dividend stocks that can grow are rare but valuable.
These stocks have been looking up over the past month.
Looking for a good starting point? You've come to the right place.
This Just In: Upgrades and Downgrades
Needham suspends clinical trial of buying Geron.
Finally Convinced? Benlysta Works!
Human Genome Sciences succeeds where others have failed.
Small Savings Add Up to a Big Payoff
Slow and steady wins the race.
Earnings? Yawn. Trial Data? Moving!
For Human Genome Sciences investors, the anticipation is frightening.
Of One-Time Gains and Pipelines
AstraZeneca had some of both during the third quarter.
Results 121 - 130 of 857 : Previous 9 10 11 12 13 14 15 16 17 Next